company

SANDVIKA NEVROSENTER AS

1337 SANDVIKA

Return on Equity
17,33 %
Current Ratio
3,57
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue37 186 000
Net Income1 986 000
Total Assets15 735 000
Total Equity11 461 000
Income (NOK)2022
Revenue37 186 000
Expenditure21 291 000
Operating Profit2 492 000
Financial Income56 000
Financial Costs1 000
Financial Balance55 000
Earnings Before Tax2 546 000
Tax560 000
Net Income1 986 000
Balance (NOK)2022
Total Fixed Assets470 000
Total Current Assets15 265 000
Total Assets15 735 000
Total Retained Equity11 431 000
Total Equity11 461 000
Total Long-Term Debt0
Total Current Debt4 274 000
Total Equity and Debt15 735 000
Cash flow (NOK)2022
Sales Income37 120 000
Other Income66 000
Revenue37 186 000
Cost of Goods Sold392 000
Salary Costs15 190 000
Depreciation445 000
Impairment0
Expenditure21 291 000
Operating Profit2 492 000
Financial Income56 000
Financial Costs1 000
Financial Balance55 000
Dividends0
Net Income1 986 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets163 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures274 000
Total Tangible Assets274 000
Total Fiancial Fixed Assets32 000
Total Fixed Assets470 000
Stock0
Total Investments0
Cash, Bank13 069 000
Total Current Assets15 265 000
Total Assets15 735 000
Total Equity11 461 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors724 000
Unpaid Taxes1 191 000
Dividends0
Other Current Debt1 768 000
Total Current Debt4 274 000
Total Equity and Debt15 735 000
Financial indicators2022
Return on Equity17,33 %
Debt-to-Equity Ratio0
Operating Profit Margin6,7 %
Current Ratio3,57
Quick Ratio3,57
Equity Ratio0,73
Gross Profit Margin98,95 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English